Australian Clinical Labs Health Care

$3.44 0.04 (1.18%)

High $3.45	Low $3.39	Trades 1,017	Turnover $1,031,103	Volume 301,613
30 June 2023 at 4:10pm

Register to track ACL and receive email alerts.

Market Cap (13-Jun) $553,822,656 (281st)	Close (30-Jun) $3.44 0 (0%)	Volume (30-Jun) 301,613	Shortsold (3-Jun) 4,125,757 (2.10%) (125th)
52w High $3.81	52w Low $2.23	P/E 13.28	EPS 0.15

	Subject
	ACL ACL Ann: HLS: Directors' Statement re Takeover
	1 (current) 2 3
	ACL ACL Ann: Response to Healius' Target's Statement
	ACL ACL Ann: Second Supplementary Bidder's Statement
	ACL ACL Ann: Takeover offer - receipt of Target's Statement
	ACL ACL Ann: HLS: Lodgement of Target's Statement
	ACL ACL Ann: Completion of dispatch of replacement bidder's statement
	ACL ACL Ann: Commencement of dispatch of replacement bidder's statement
	ACL ACL Ann: Notice of EGM
	ACL ACL Ann: TOV: HLS Panel Declines to Conduct Proceedings
	ACL ACL Ann: ASX announcement - Replacement Bidder's Statement
	ACL ACL Ann: Replacement Bidder's Statement
	ACL ACL Ann: First Supplementary Bidder's Statement
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: Change in substantial holding
	ACL ACL Ann: TOV: HLS Panel Receives Application
	ACL ACL Ann: Update - Dividend/Distribution - ACL
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Suspension of DRP
	ACL ACL Ann: HLS: Directors' Statement re Takeover
	ACL ACL Ann: Proposed issue of securities - ACL
	ACL ACL Ann: Becoming a substantial holder for HLS
	ACL ACL Ann: People to whom information is to be sent
	ACL ACL Ann: HLS: Off-market takeover bid from ACL
	ACL ACL Ann: Investor Webinar - Takeover Offer for Healius
	ACL ACL Ann: Investor Presentation - Takeover Offer for Healius
	ACL ACL Ann: Bidder's Statement in relation to Takeover Offer for Healius
	ACL ACL Ann: Takeover Offer for Healius Limited
	ACL ACL Ann: Notification regarding unquoted securities - ACL
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Notification regarding unquoted securities - ACL
	ACL ACL Ann: Notification of cessation of securities - ACL
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Dividend/Distribution - ACL
	ACL ACL Ann: 1H23 results investor presentation
	ACL ACL Ann: Appendix 4D and 1H23 financial reports
	ACL ACL Ann: 1H23 Financial Results release details
	ACL ACL Ann: Release of Shares from Voluntary Escrow
	ACL ACL Ann: Medlab Cyber Incident Update
	ACL ACL Ann: Ceasing to be a substantial holder
	ACL ACL Ann: Becoming a substantial holder
	ACL ACL Ann: Medlab Pathology Cyber Incident
	ACL ACL Ann: 2022 AGM - Results of Meeting
	ACL ACL Ann: 2022 AGM - addresses to shareholders
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Director Appointment/Resignation
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Change of Director's Interest Notice
	ACL ACL Ann: Ceasing to be a substantial shareholder
	ACL ACL Ann: 2022 Annual Report and Corporate Governance Statement
	ACL ACL Ann: Appendix 4G

Register to track ACL and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
12-Jun	$2.82	720,385	+0.05 (1.81%)
06-Jun	$2.77	2,811,277	-0.01 (0.36%)
05-Jun	$2.78	423,316	0.00 (0.00%)
04-Jun	$2.78	630,614	-0.01 (0.36%)
03-Jun	$2.79	3,417,740	-0.03 (1.06%)
02-Jun	$2.82	933,019	-0.03 (1.05%)
30-May	$2.85	2,351,545	-0.08 (2.73%)
27-May	$2.93	676,650	-0.05 (1.68%)
26-May	$2.98	928,499	+0.03 (1.02%)
23-May	$2.95	853,918	-0.02 (0.67%)
22-May	$2.97	1,214,739	-0.11 (3.57%)
21-May	$3.08	384,899	-0.02 (0.65%)
19-May	$3.10	533,105	-0.02 (0.64%)
16-May	$3.12	1,094,945	+0.07 (2.30%)
15-May	$3.05	925,652	+0.01 (0.33%)
4 up, 10 down, and 1 flat days